Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

19 Jul 2024 Evaluate
Zydus Lifesciences has informed that it enclosed press release ‘Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR (sitagliptin and metformin hydrochloride) extended-release tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..